Comparison of superoxide dismutase, glutathione peroxidase and adenosine deaminase activities between respiratory and nocturnal subtypes of patients with panic disorder

Neuropsychobiology

Volumn 66, Issue 4, 2012, Pages 244-251

  Ozdemir, Osman ^a   Selvi, Yavuz ^b   Ozkol, Halil ^b   Tuluce, Yasin ^b   Besiroglu, Lutfullah ^b   Aydin, Adem ^b  

^a Ipekyolu Public Hospital   (Turkey)

^b YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Glutathione peroxidase; Panic disorder; Superoxide dismutase

Indexed keywords

ADENOSINE DEAMINASE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OXIDATIVE STRESS; PANIC; PANIC AND AGORAPHOBIA SCALE; PANIC ATTACK SYMPTOM CHECKLIST; PATHOGENESIS; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; SUPEROXIDE DISMUTASE;

EID: 84867689709     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000341880     Document Type: Article

References (47)

1. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders. Washington, American Psychiatric Press, 2000.
2. Kircanski K, Craske MG, Epstein AM, Wittchen H: Subtypes of panic attacks: a cr it-ical review of the empirical literature. Depress Anxiety 2009; 26:878-887.
3. Sarp A, Arik AC, Guz H, Sahin AR, Abanoz Z: Possible subtypes of panic disorder. Turk Psik iyatri Derg 2010; 21:269-279.
4. Mellman TA, Uhde TW: Sleep panic attacks: new clinical findings and theoretical implications. Am J Psychiatry 1989; 146:1204-1207.
5. Craske MG, Barlow DH. Nocturnal panic. J Nerv Ment Dis 1989; 177:160-167.
6. Agargun MY, Kara H: Recurrent nocturnal panic, insomnia, and suicidal behavior in patients with panic disorder. Compr Psychiatr 1998; 39:149-151.
7. Briggs AC, Stretch DD, Brandon S: Subtyping of panic disorder by symptom profile. Br J Psychiatry 1993; 163:201-209.
8. Valence AM, Nardi AE, Nascimento I, Zin WA, Versiani M: Respiratory panic disorder subtype and sensitivity to the carbon dioxide challenge test. Braz J Med Biol Res 2002; 35:783-788.
9. 2 challenge. Am J Psychiatry 1999; 156:739-744.
10. Abrams K, Rassovsky Y, Kushner MG: Evidence for respiratory and non-respiratory subtypes in panic disorder. Depress Anxiety 2006; 23:474-481.
11. Gutteridge JMC: Lipid peroxidation and an-tioxidants as biomarkers of tissue damage. Clin Chem 1995; 41:1819-1828.
12. Brown MK, Naidoo N: The UPR and the an-ti-oxidant response: relevance to sleep and sleep loss. Mol Neurobiol 2010; 42:103-113.
13. Ozkol H, Koyuncu I, Tuluce Y: Some medicinal plants counteract alterations of neuroendocrine stress response system, oxidative and nitrosative stress caused by repeated restraint in rats. J Med Plants Res 2011; 5:4360-4368.
14. Kuloglu M, Atmaca M, Tezcan E, Ustundag B, Bulut S: Antioxidant enzyme and malo-nd ia ldehyde levels in patients with pa nic disorder. Neuropsychobiology 2002; 46:86-89.
15. Ozkol H, Tuluce Y, Koyuncu I: Subacute effect of cigarette smoke exposure in rats: protection by pot marigold (Calendula officina-lis L.) extract. Toxicol Ind Health 2012; 28:3-9.
16. Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Tunckol H: Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci 2004; 254:231-235.
17. Bilici M, Efe H, Koroglu MA, Uydu HA, Bek-aroglu M, Deger O: Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64:43-51.
18. Herken H, Uz E, Ozyurt H, Sogut S, Virit O, Akyol O: Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry 2001; 6:66-73.
19. Savas HA, Herken H, Yurekli M, Uz E, Tut-kun H, Zoroglu SS: Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 2002; 45:57-61.
20. Kim YR, Park Q, Yu BH: Changes in lymphocyte subsets after short-term pharmacother-apy in patients with panic disorder. Psychiatry Res 2004; 128:183-190.
21. Manfro GG, Pollack MH, Otto MW, et al: Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depress Anxiety 2000; 11:31-37.
22. Herken H, Akyol O, Yilmaz HR, Tutkun H, Savas HA, Ozen ME: Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment. Hum Psychopharmacol 2006; 21:53-59.
23. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders. Washington, American Psychiatric Press, 1994.
24. First MB, Spitzer LR, Gibbon M, et al: Structured Clinical Interview for Axis I Disorders (SCID-I), Clinical Version. Washington, American Psychiatric Press, 1997.
25. Corapcioglu A, Aydemir O, Yildiz M, et al: Structured Clinical Interview for DSM-IV (SCID-I), Türkçe Formu. Ankara, Hekimler Yayin Birliǧi, 1999.
26. Bandelow B: Assessing the efficacy of treatments for panic disorder and agoraphobia. 2. The panic and agoraphobia scale. Int Clin Psychopharmacol 1995; 10:73-81.
27. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
28. Akdemir A, Orsel SD, Dag I, et al: Hamilton Depresyon Derecelendirme Ölçeǧi (HDDÖ) 'nin geçerliǧi- güvenirliǧi ve klinikte kullanimi. Psikiyatri Psikofarmakoloji Der-gisi 1996; 4:251-259.
29. Hamilton M: The assessment of anxiety status by rating. Br J Med Psychol 1959; 32:50-55.
30. Yazici MK, Demir B: Hamilton anksiyete deǧerlendirme ölçeǧi, deǧerlendiriciler arasi güvenirlik ve geçerlik çalişmasi, Türk Psiki-yat ri Derg 1998; 9:114-117.
31. Fidaner H, Tunca Z, Cimilli C, et al: Clinical characteristics of attacks in panic disorder: a study with Q methodology. Türk Psikiyatri Derg 1998; 9:277-283.
32. Orsel S, Guruz O, Akdemir A, Türkçapar H: The determination of panic disorder subtypes according to symptoms. Klinik Psiki-yatri 2003; 6:204-212.
33. Selvi Y, Ozkol H, Tuluce Y, Besiroglu L, Oz-demir PG: Chronotypes and oxidative stress: is there an association? Biol Rhythm Res DOI:10.1080/09291016. 2010.548927.
34. Giusti G: Adenosine deaminase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, vol 2, pp 1092-1099.
35. Lowry OH, Rosebrough NJ, Farr AL: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275.
36. Felicity N, Berk M, Dean O, Bush AI: Oxida-tive stress in psychiatric disorders: evidence base and therapeutic implications. J Int Neu-ropsychopharm 2008; 11:851-876.
37. Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006; 6:318-328.
38. Schleifer SJ, Keller SE, Bartlett JA: Panic disorder and immunity: few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav Immun 2002; 16:698-705.
39. Faravelli C: Life events preceding the onset of panic disorder. J Affect Disord 1985; 9:103-105.
40. Savoia MG, Bernik M: Adverse life events and coping skills in panic disorder. Rev Hosp Clin Fac Med Sao Pau lo 2004; 59:337-340.
41. Yarpuz AY, Yilmaz A, Soykan A, Elgun S, Kumbasar H: Levels of adeno sine deaminase and dipeptidyl peptidase IV in patients with panic disorder. Turk Psi kiyatri Derg 2008; 9:149-156.
42. Wright RJ, Rodriguez M, Cohen S: Review of psychosocial stress and asthma: an integrated biopsychosocial approach. Thorax 1998; 53:1066-1074.
43. Friedman BH, Thayer JF: Autonomic balance revisited: panic anxiety and heart rate variability. J Psychosom Res 1998; 44:133-151.
44. Johnston L: Non-Hodgkin's Lymphomas: Making Sense of Diagnosis, Treatment, and Options. Patient-Centered Guides. Sebasto-pol, O'Reilly Media, 1999.
45. Ersoy MA, Selek S, Celik H, Erel O, Kaya MC, Savas HA, Herken H: Role of oxidative and antioxidative parameters in etiopathogene-sis and prognosis of panic disorder. Int J Neurosci 2008; 118:1025-1037.
46. Agargun MY, Kara H: Nocturnal panic in patients with panic disorder: the association with major depression. Eur Psychiatry 1997; 12:42-43.
47. Massana J, Lopez Risueno JA, Massana G: Subtyping of panic disorder patients with bradycardia. Eur Psychiatry 2001; 16:109-114.